Literature DB >> 14871552

Ca2+-dependent modulation of single human cardiac L-type calcium channels by the calcineurin inhibitor cyclosporine.

Jan Matthes1, Andreas Jäger, Renate Handrock, Ferdi Groner, Uwe Mehlhorn, Robert H Schwinger, Gyula Varadi, Arnold Schwartz, Stefan Herzig.   

Abstract

OBJECTIVE: Activity of single L-type calcium channels (LTCC) is enhanced in human failing myocardium (Circulation 98 (1998) 969.), most likely due to impaired dephosphorylation. Protein phosphatase 2B (calcineurin) has recently been shown to be involved in heart failure pathophysiology. We now focus on the regulation of single LTCC by calcineurin that were prevented by Ca(2+)-free experimental conditions in our previous study.
METHODS: Single LTCC currents were recorded in myocytes from human atrium and ventricle. Charge carriers were 70 mM Ba(2+), or a mixture of 30 mM Ca(2+) and 60 mM Ba(2+) to facilitate Ca(2+) permeation through recorded channels. The calcineurin inhibitor cyclosporine (10 microM) was used to reveal a putative role for calcineurin in regulation of LTCC.
RESULTS: A mixture of Ca(2+) and Ba(2+) as charge carriers allowed for Ca(2+) permeation through recombinant human embryonic kidney cells and native (atrial and ventricular) human cardiac LTCC. With only Ba(2+) as the charge carrier, activities of both ventricular and atrial LTCC were strongly decreased by cyclosporine. In contrast, channel activity remained constant when Ca(2+) permeation was provided. In the presence of thapsigargin and (S)-BayK 8644, cyclosporine here even increased channel activity.
CONCLUSIONS: We propose a dual cyclosporine effect on human cardiac LTCC. A non-specific inhibitory effect prevails with Ba(2+) permeation but can be compensated or overcome by a specific Ca(2+)-dependent stimulation with Ca(2+) permeation. More complete restoration of physiological Ca(2+) movements (e.g., Ca(2+) release from sarcoplasmic reticulum) will help to define even more precisely the involvement of calcineurin in regulation of human cardiac LTCC.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14871552     DOI: 10.1016/j.yjmcc.2003.11.013

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  5 in total

Review 1.  Calcium handling in human heart failure--abnormalities and target for therapy.

Authors:  Hannes Reuter; Robert H G Schwinger
Journal:  Wien Med Wochenschr       Date:  2012-06-12

2.  Inhibition of serine/threonine phosphatase enhances arachidonic acid-induced [Ca2+]i via protein kinase A.

Authors:  Tomoyuki Saino; Eileen L Watson
Journal:  Am J Physiol Cell Physiol       Date:  2008-11-05       Impact factor: 4.249

3.  Physical and functional interaction between calcineurin and the cardiac L-type Ca2+ channel.

Authors:  Samvit Tandan; Yanggan Wang; Thomas T Wang; Nan Jiang; Duane D Hall; Johannes W Hell; Xiang Luo; Beverly A Rothermel; Joseph A Hill
Journal:  Circ Res       Date:  2009-05-28       Impact factor: 17.367

4.  Increased expression of the auxiliary beta(2)-subunit of ventricular L-type Ca(2)+ channels leads to single-channel activity characteristic of heart failure.

Authors:  Roger Hullin; Jan Matthes; Sibylle von Vietinghoff; Ilona Bodi; Marta Rubio; Karen D'Souza; Ismail Friedrich Khan; Dennis Rottländer; Uta C Hoppe; Paul Mohacsi; Eva Schmitteckert; Ralf Gilsbach; Moritz Bünemann; Lutz Hein; Arnold Schwartz; Stefan Herzig
Journal:  PLoS One       Date:  2007-03-14       Impact factor: 3.240

5.  Increased Retention of Cardiac Cells to a Glass Substrate through Streptavidin-Biotin Affinity.

Authors:  Kara A Davis; Jensen Z Goh; Andrea H Sebastian; Brooke M Ahern; Christine A Trinkle; Jonathan Satin; Ahmed Abdel-Latif; Brad J Berron
Journal:  ACS Omega       Date:  2021-07-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.